The nation of Zimbabwe has turned down a substantial American healthcare agreement valued at 367 million US dollars (£272m) over five years over the United States' demand for sensitive biological samples.
This rejection was revealed after a official document dated December was leaked, which showed President Emmerson Mnangagwa deemed the deal was "skewed".
An official representative has since stated that the US was requesting health data for research and commercial gain but was unwilling to share the resulting advantages from future vaccines.
"We are forced to start the challenging and unfortunate task of scaling back our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had donated over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has appealed for more dialogue to secure a deal acceptable to both sides so the nation's critical HIV programme can continue.
Wider Background
This development comes after a similar situation in neighbouring Kenya, where a court halted a related health funding agreement following concerns were raised about the safety of Kenyans' medical information.
Since resuming the presidency recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
The agency had administered assistance for the American government, but Trump stated its expenditure was "inefficient" and his government was seeking government-to-government deals to enhance transparency and accountability.
As per reports, Sixteen nations in Africa have so far agreed to similar health pacts, constituting more than $18.3bn in committed funds.
Details of the Rejected Agreement
The money for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this partnership could have provided immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently on HIV treatment through US-supported programmes," Tremont said.
However, official spokesman Nick Mangwana maintained the arrangement was "asymmetrical".
"Zimbabwe was being asked to surrender its biological resources and data over an extended period, without any equivalent assurance of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.
"In essence, our nation would supply the basic resources for scientific discovery with no certainty that the resulting innovations would be available to our people should a future disease outbreak arise."
National Interest and International Frameworks
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining frameworks previously set up via the global organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to deal with future global health emergencies.
"This system is intended to guarantee that when a country provides its samples, the benefits – including medicines and cures – are shared equitably, not monopolised exclusively by those with the resources to develop them."
These objections regarding the US deal "must not be interpreted as opposition to America," he added.
"We are open to further discussions with our American counterparts on how subsequent co-operation might be designed in a way that honours the sovereignty and dignity of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but suggested that negotiations must proceed considering a large portion of the country's HIV programmes relied on external financing.
"Where technical issues arise, such as those involving information security or implementation frameworks, these can frequently be resolved via detailed discussion and negotiated safeguards," it added.
The halted deal emphasises the continuing challenges between accepting crucial international aid and safeguarding national sovereignty in an increasingly interconnected world.